• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problems Infusion or Flow Problem (2964); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Fall (1848); Hemorrhage/Bleeding (1888); Laceration(s) (1946); Blood Loss (2597)
Event Date 12/19/2020
Event Type  Death  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
It was reported that the patient fell and had multiple facial lacerations.The patient also had internal bleeding.The patient experienced continuous low flow alarms with low mean arterial pressures in the 30's upon emergency department arrival.The low flow alarms were noted and the controller showed the red heart illuminated with a continuous audible tone.The patient subsequently expired and no autopsy would be done.
 
Event Description
It was reported that the cause of death was internal bleeding.It was also noted that the cause of the low flow alarms was internal bleeding.The low flow alarms did not resolve before the patient's death.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause for the reported bleeding, as well as a direct correlation to heartmate 3 lvas, serial number (b)(6), could not conclusively be determined through this investigation.Although a specific cause for the reported low flow events could not conclusively be determine through this evaluation, the account communicated that they were due to bleeding.The relevant sections of the device history records for (b)(6), were reviewed and showed no deviations from manufacturing or quality assurance specifications.The pump was shipped on (b)(6) 2018.The current heartmate 3 lvas ifu lists bleeding and death as adverse events that may be associated with the use of heartmate 3 left ventricular assist system in section 1 ¿introduction¿.Section 6 ¿patient care and management¿ provides information regarding anticoagulation, including the recommended inr values.The heartmate 3 lvas ifu contains a section on ¿pump performance monitoring¿ under patient care and management which explains that pump performance is sensitive to changes in systemic vascular resistance and left ventricular filling.Section 4.4 ¿clinical screen¿, contains sections on pump flow, pump speed, pulsatility index, and pump power.Per design, when the estimated flow value is calculated at less than 2.5 lpm, a low flow status is posted to the log file.If the flow remains below 2.5 lpm for 10 seconds, a low flow hazard alarm is triggered.The heartmate 3 patient handbook contains a section on ¿alarms and troubleshooting¿ which provides information on all system alarms and the actions associated to resolve the alarms.A section on ¿handling emergencies¿ is also provided.The heartmate 3 instructions for use (ifu) list bleeding and death as adverse events that may be associated with the heartmate 3 left ventricular assist system.This ifu provides information regarding anticoagulation, including the recommended inr values.The heartmate 3 lvas ifu explains that pump performance is sensitive to changes in systemic vascular resistance and left ventricular filling and outlines all pump parameters.Per design, when the estimated flow value is calculated at less than 2.5 lpm, a low flow status is posted to the log file.If the flow remains below 2.5 lpm for 10 seconds, a low flow hazard alarm is triggered.The heartmate 3 patient handbook states that in the event of a low flow hazard alarm, call the hospital contact immediately for diagnosis and instructions.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key11156815
MDR Text Key226349394
Report Number2916596-2020-06544
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/04/2021
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number6612127
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age74 YR
Patient Weight95
-
-